Research & Clinical Trials

The National Center for Regenerative Medicine (NCRM) supports investigators conducting innovative research translating into cell-based therapies and technologies.

NCRM’s comprehensive bench-to-bedside approach requires partnering with researchers and institutions to support programs in the areas of:

  • Basic research
  • Clinical research 
  • Biomedical/tissue engineering research

Using stem cells to regenerate new tissue in diseased organs, instead of using drugs or devices, represents a new paradigm in biomedical research. NCRM’s collaborative partnerships have advanced research discoveries and therapeutic uses of stem cells for the following:

  • Cardiovascular disease
  • Adult stem cell transplantation
  • Cancer
  • Genetic disorders
  • Musculoskeletal conditions
  • Neurodegenerative conditions
Investigator Institution Cell Type Disease Target

A. Sloan, S. Gerson

UHCMC/CWRU Autologous HPCs Advanced Malignancies

H. Lazarus

UHCMC/CWRU Allogeneic MSCs GVHD

S. Ellis, D. Simon

CCF, UHCMC Autologous MNCs Acute MI and Heart Failure

A. Sloan, L. Metheny, S. Gerson

UHCMC/CWRU, NIH Autologous HPCs Glioblastoma

J. Cohen

CCF Autologous MSCs Multiple Sclerosis

M. deLima, L. Metheny

UHCMC/CWRU Allogeneic MSCs Leukemia

J. Miller

UHCMC
 
Gene modified allogenic MSCs Stroke

J. Chmiel

UHCMC/CWRU Allogeneic MSCs Cystic Fibrosis

J. Baar

UHCMC/CWRU Autologous dendritic cell vaccine Breast Cancer

M. Murphy

Indiana University Allogeneic MSCs Aortic Aneurysm and Limb Ischemia

N. Singer

Metro Allogeneic MSCs Rheumatoid Arthritis

P. Caimi

UHCMC/CWRU Autologous CD19 CAR-T Lymphoma

F. Otegbeye, D. Wald

UHCMC/CWRU Allogeneic NK cells Heme Malignancies and Colorectal Cancer

J. Jacobson

UHCMC/CWRU, U Cincinnati, UCSF Autologous gene edited T cells HIV

A. Lightner

CCF Allogeneic MSCs Inflammatory Bowel

B. Tomlinson

UHCMC/CWRU Autologous CD19 CAR-T Leukemia, Lymphoma

S. Deeks

UCSF, UC Davis Autologous duo CAR-T HIV

J. Voos

UHCMC Autologous MSCs Osteoarthritis and Chondral Defects

P. Caimi, L. Metheny

CCF, UHCMC Autologous BAFF CAR-T Lymphoma, Multiple Myeloma

G. Deng, D. Wald

UHCMC, CCF, U Iowa Autologous ultra fast CAR-T Lymphoma